Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease

Summary

To investigate the blood-retinal barrier permeability and the inner limiting membrane integrity in animal models of retinal disease, we used several adeno-associated virus (AAV) variants as tools to label retinal neurons and glia. Virus mediated reporter gene expression is then used as an indicator of retinal barrier permeability.

Abstract

Müller cells are the principal glial cells of the retina. Their end-feet form the limits of the retina at the outer and inner limiting membranes (ILM), and in conjunction with astrocytes, pericytes and endothelial cells they establish the blood-retinal barrier (BRB). BRB limits material transport between the bloodstream and the retina while the ILM acts as a basement membrane that defines histologically the border between the retina and the vitreous cavity. Labeling Müller cells is particularly relevant to study the physical state of the retinal barriers, as these cells are an integral part of the BRB and ILM. Both BRB and ILM are frequently altered in retinal disease and are responsible for disease symptoms.

There are several well-established methods to study the integrity of the BRB, such as the Evans blue assay or fluorescein angiography. However these methods do not provide information on the extent of BRB permeability to larger molecules, in nanometer range. Furthermore, they do not provide information on the state of other retinal barriers such as the ILM. To study BRB permeability alongside retinal ILM, we used an AAV based method that provides information on permeability of BRB to larger molecules while indicating the state of the ILM and extracellular matrix proteins in disease states. Two AAV variants are useful for such study: AAV5 and ShH10. AAV5 has a natural tropism for photoreceptors but it cannot get across to the outer retina when administered into the vitreous when the ILM is intact (i.e., in wild-type retinas). ShH10 has a strong tropism towards glial cells and will selectively label Müller glia in both healthy and diseased retinas. ShH10 provides more efficient gene delivery in retinas where ILM is compromised. These viral tools coupled with immunohistochemistry and blood-DNA analysis shed light onto the state of retinal barriers in disease.

Introduction

Müller cells are the major glial component of the retina. Morphologically, they span the retina radially and their endfeet, in contact with the vitreous, face the ILM and secret components of the latter. The ILM is a basement membrane composed of about ten different extracellular matrix proteins (laminin, agrin, perlecan, nidogen, collagen and several heparin sulfate proteoglycans). During development, its presence is indispensable for retinal histogenesis, navigation of optic axons, and survival of ganglion cells^1-3. However, ILM is unessential in adult retina and can be surgically removed in certain pathologies without causing retinal damage⁴. In gene therapy, this membrane becomes a physical barrier for efficient transduction of the retina using AAVs by intravitreal injection⁵.

Through the extensive arborization of their processes, Müller cells provide nutritional and regulatory support to both retinal neurons and vascular cells. Müller cells are also involved in the regulation of the retinal homeostasis, in the formation and maintenance of the BRB⁶. Tight junctions between retinal capillary endothelial cells, Müller cells, astrocytes and pericytes form the BRB. BRB prevents certain substances from entering the retina.In many diseases like diabetic retinopathy, retinal vein occlusion and respiratory diseases, hypoxia of the retina causes leakage through the BRB^7-9. This rupture is associated with an increase in vascular permeability leading to vasogenic edema, retinal detachment and retinal damage.

Müller cells are tightly associated with blood vessels and the basement membrane, playing an important role in both BRB and ILM integrity. Consequently, labeling Müller glial cells is particularly relevant to the study of the physical state of these retinal barriers.

Classically, BRB permeability is measured using the Evans blue assay consisting of systemic injection of Evans blue dye, which binds non-covalently to plasma albumin. This assay measures the albumin leakage (protein of intermediate size, ~66 kDa) from blood vessels into the retina (see Protocols Section 5)¹⁰. Alternatively, the vascular leakage can be visualized by fluorescence retinal angiography attesting for leakage of fluorescein (small molecule, ~359 Da; see Protocols Section 6)¹¹. Nevertheless, both methods allow evaluation of the BRB permeability to small molecules and proteins but they do not provide information about the ILM integrity.

Hence, to study BRB permeability, we used an AAV based method that gives information on the BRB permeability to larger molecules (e.g., AAV particles, 25 nm diameter). Indeed, our method can detect presence of AAV transgene in the blood, which would suggest that ~25 nm diameter particles would be able to infiltrate into the bloodstream. This method also provides information on the structure of the ILM and extracellular matrix proteins in pathological conditions. Two AAV variants are useful for such study: AAV5 and ShH10. Subretinally injected, AAV5 has a natural tropism for photoreceptors and retinal pigment epithelium¹² but it cannot get across to the outer retina when administered into the vitreous in wild-type retinas with intact ILM^5,13. ShH10 is an AAV variant that has been engineered to specifically target glial cells over neurons^14,15. ShH10 selectively labels Müller cells in both healthy and diseased retinas with increased efficiency in retinas with compromised barriers¹⁶. These viral tools coupled with immuhistochemistry and blood-DNA analysis provide information on the state of retinal barriers and their involvement in disease (Figure 1).

Protocol

All animals used in this study were cared for and handled according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

1. Production of Recombinant AAV (rAAV) by Transient Transfection of HEK-293 Cells^17,18

NOTE: See McClure C, JoVE (2011)¹⁹.

1. Purify a large-scale plasmid preparation (at least 1 mg/ml) of the AAV vector plasmids. Use 3 plasmids. The AAV helper plasmid carrying the replication and capsid genes without the AAV inverted terminal repeats ITRs, the transgene expression cassette carrying the AAV ITR referred to as the transfer plasmid, and the plasmid supplying the adenovirus helper genes E2, E4, and VA RNA genes referred to as pHELPER.
2. Transfect 293 cells with these 3 plasmids using polyethyleneimine (or other transfection reagent). Above 80% of transfection efficiency is necessary for good viral yields.
3. Purify recombinant AAV from 293 cell lysates on an iodixanol gradient. 15%, 25%, 40%, and 60% iodixanol is used to obtain the gradient. Collect 40% iodixanol fraction containing AAV particles, concentrate the fraction after ultracentrifugation at 500,000 x g for 1 hr and buffer exchange against PBS (phosphate buffered saline) with 0.001% Pluronic.
4. To determine viral genomic titer²⁰, perform a DNAse ProteinaseK digest followed by QPCR. The forward and reverse primers amplify the 62 bp region located in the AAV2 ITR. For the plasmid standard, the probe is labeled with FAM and has a black hole quencher (BHQ).
5. Carry out qPCR (quantitative polymerase chain reaction)  in a final volume of 25 μl using 340 nM reverse ITR primer, 100 nM forward ITR primer, 100 nM AAV2 ITR probe, 0.4 mM dNTPs, 2 mM MgCl2, 1x Platinum Taq Buffer, 1U Platinum Taq and 5 μl template (standard, sample and no template control).
6. For the standard, use the plasmid for transfection in 7 x 10-fold serial dilutions (5 µl each of 2 x 10⁹ to 2 x 10³ genomes/ml resulting in a final concentration from 10¹⁰ to 10⁴ genomes/ml).
7. Begin the program by an initial denaturation step at 95 °C for 15 min followed by 40 cycles of denaturation at at 95 °C for 1 min and annealing/extension at 60 °C for 1 min. Store at 4 °C for a short-term storage or at -20 °C for long storage periods.

2. Intravitreal Injection of AAV

1. Anesthetize C57BL6J mice with ketamine (50 mg/kg) and xylazine (10 mg/kg) and verify the loss of righting reflex, the withdrawal reflex and tail pinch response indicating a proper anesthetization. Dilate pupils by corneal application of neosynephrine 5% and mydriaticum 0.5% eye drops. Use vet ointment on eyes to prevent dryness while under anesthesia.
2. Pass an ultrafine 30 G disposable needle through the equator and next to the limbus, into the vitreous cavity (see Chiu K, JoVE (2007)²¹). Inject 1 µl stock containing 1 to 4 x 10¹¹ vp of ShH10-GFP or AAV5-GFP with direct observation of the needle in the center of the vitreous cavity (Figure 1). Use one eye as a control for ILM experiments. Inject both eyes for BRB experiments. Apply an anti-inflammatory and antibacterial topical treatment on injected eyes.
3. Dilate pupils with neosynephrine and mydriaticum eye drops for imaging. Perform fundus examinations with an eye fundus camera to follow GFP (Green Fluorescent Protein) expression 1 week, 2 weeks, 1 month, and 2 months after intravitreal injection (Figure 1). Sacrifice mice by CO₂ inhalation 1 to 2 months post-injection.

3. Immunohistochemistry

1. For retinal cryosections (Figure 1), dissect enucleated eyes to remove lens and cornea, and immersion fix in 4% paraformaldehyde for 1 hr.
   1. Cryoprotect the previously fixed eyes in 10% sucrose for 1 hr at room temperature, 20% sucrose for another hr at room temperature. Cryoprotect in 30% sucrose solution, overnight at 4 °C. Freeze and embed eyecups in embedding resin such as Cryo-matrix. Make 10 µm cryosections and mount on slides specially treated for frozen tissue sections and that improve tissue adherence during staining.
   2. Permeabilize sections with 0.1% Triton X100 in PBS pH 7.4 for 5 min. Wash 2x in PBS and block for 1 hr at room temperature in PBS with 1% BSA, 0.1% Tween 20.
2. For retinal flatmounts (Figure 1), fix enucleated eyes in 4% paraformaldehyde for 15 min to facilitate the dissection.
   1. In 15-30 min, dissect the eyes to remove the cornea and lens. Separate the retina from the retinal pigment epithelium (RPE) and sclera by cutting around the ora serrata and the optic nerve. Immerse in 4% paraformaldehyde for another 30 min to fix the retina and the fluorescent protein in transduced retinal cells (fixation must not exceed 24 hr). Wash 5 min in sterile PBS, pH 7.4.
   2. Change the PBS to blocking buffer (PBS with 1% BSA, 2% normal goat or donkey serum, 0.5% Triton X-100), and incubate in blocking buffer for either 4 hr at room temperature or 4 °C overnight.
3. Incubate tissues with primary antibodies in blocking buffer for either 4 hr at room temperature or at 4 °C overnight. Wash 3x with PBS.
   NOTE: The antibodies used are as follows: anti-laminin (1/1,000) labeling the ILM, anti-rhodopsin clone 4D2 (1/500) labeling rods, anti-glutamine synthetase clone GS-6 (1/1,500) labeling Müller cells, PNA Lectin (1/40) labeling cones.
4. Incubate tissues with 1:500 dilution of alexa fluor conjugated secondary antibodies in blocking buffer for 1 hr (cryosections) or 2 hr (flatmounts) at room temperature and protected from light. Wash 3x with PBS.
5. Make relieving cuts to the retina and flatmount it onto a glass slide with either the photoreceptor or retinal ganglion cell (RGC) side facing upwards. Add aqueous mountingmedium, apply coverslip and store at 4 °C.
6. Perform confocal microscopy on laser-scanning confocal microscope. Acquire images sequentially, line by line, to reduce excitation and emission crosstalk. Define step size according to the Nyquist–Shannon sampling theorem. Use exposure settings that minimize oversaturated pixels in the final images. Process 12-bit images with FIJI, project Z-sections on a single plane using maximum intensity under Z-project function and finally convert to 8-bit RGB color mode.

4. PCR Analysis of Mouse Blood Samples

1. Inject 100 µl stock containing 1 to 4 x 10¹¹ particles of an AAV-GFP into the penile vein of anesthetized C57BL6J mice (5% of isoflurane for induction in a close chamber and 2.5% of isoflurane through a nose cone during surgery) using an insulin syringe with an ultra-fine 6 mm needle. This animal will serve as a positive control of circulating AAV particles.
2. Sample blood from mouse tail before injection and 3 hr, 24 hr, 2 days, and 3 days after ShH10 intravitreal injection or after intrapenile injection (Figure 1). About 10-20 µl is collected in heparin tubes. Sacrifice mice by CO₂ inhalation after completion of the procedure.
3. Extract genomic DNA from blood samples using the extraction kit of your choice.
4. Perform PCR amplification of genomic DNA. For this protocol use the following primer pair: GFP, sense 5’-CGACACAATCTGCCCTTTCG-3’, antisense 5’-CATGGACGAGCTGTACAAGGGA-3’. The following PCR program was performed: 95 °C 2 min (1 cycle); 95 °C 45 sec, 55 °C 1 min, 72 °C 45 sec (30 cycles); 72°C 5 min (1 cycle); 4 °C hold.

5. Optional Evans Blue Method

NOTE: Quantify vascular permeability by measuring albumin leakage from blood vessels into the retina using the Evans blue method¹⁰.

1. Prepare Evans Blue dye by dissolution in a normal saline solution (6 mg/ml), sonication for 5 min in an ultrasonic cleaner, and filtration through a 5 µm filter.
2. Anesthetize C57BL6J mice (isoflurane inhalation, see step 4.1), check the loss of righting reflex, the withdrawal reflex and tail pinch response indicating a proper anesthetization, and inject Evans blue (45 mg/kg) through the penile vein (Figure 1). Check that paws, muzzle, and ears of mice become clearly blue following Evans blue injection, confirming the uptake and distribution of the dye.
3. Anesthetize C57BL6J mice 3 hr after injection of the dye with ketamine (50 mg/kg) and xylazine (10 mg/kg) and verify the loss of righting reflex indicating a proper anesthetization. Sample intracardially about 500 µl of blood in heparin tubes and perfuse mice for 2 min via the left ventricle with a citrate buffer (0.05 M, pH 3.5; dissolve 7.8 g of citric acid and 3.8 g of sodium citrate in 1 L of distilled water) pre-warmed to 37 °C to prevent vasoconstriction. Mice are sacrificed via the perfusion.
4. After perfusion, enucleate and carefully dissect both eyes under an operating microscope to collect the retinas (see Section 3.2). Dry retinas in a centrifugal evaporator overnight, weigh, and extract the Evans blue dye by incubating retinas with 100 μl of formamide for 18 hr at 65 °C with shaking (100 x g). Centrifuge retina samples in 30K omega filter tubes at 20,798.5 x g for 2 hr at 4 °C and centrifuge blood samples at 20,798.5 x g for 15 min at 4 °C.
5. Use both supernatants to measure absorbance. Determine absorbance of each sample by subtracting the absorbance maximum for Evans blue at 620 nm to the absorbance minimum at 740 nm. Calculate Evans blue concentration in plasma and retina from a standard curve of Evans blue in formamide. Express BRB permeability in microliter of Evans blue per gram of dry retina per hour (µl plasma/g retinal dry wt/hr).

6. Optional Fluorescein Angiography

NOTE: Leakage from retinal blood vessels in mice can be visualized by intraperitoneal injection of sodium fluorescein.

1. Anesthetize C57BL6J mice (isoflurane inhalation, see step 4.1) and dilate pupils with eye drops (neosynephrine and mydriaticum). Use vet ointment on eyes to prevent dryness while under anesthesia.
2. Inject intraperitoneally 0.01-0.02 ml of 10% sodium fluorescein in 0.1 ml sterile saline for fluorescein angiography.
3. Collect images of both eyes after injection using an eye fundus camera. Sacrifice mice by CO₂ inhalation after the procedure.
   NOTE: 20 sec are necessary for the retinal vessels to become visible on angiography. Images have to be captured between 3-10 min maximum after fluorescein injection. The leakage spots (if present) are observable after 2.5 min. At later time points the image quality is lost due to sodium fluorescein diffusing into the vitreous, thus only images shortly obtained after are used for analysis.

Results

We expect increased retinal transduction of Müller glial cells using ShH10 if the animal model shows perturbations in the structure of the ILM (Figure 2A-B). For example, we have shown that in absence of Dp71, ShH10 targets specifically but more efficiently Müller glial cells by intravitreal injection, indicating increased permeability of the ILM in this mouse line compared to wild-type mice¹⁶ (Figure 2C-F).

Discussion

The BRB regulates the exchange of molecules between blood and retina. Its breakdown is associated with various diseases such as diabetic retinopathy or age-related macular degeneration (AMD). We recently showed that in a dystrophin knock-out mouse, which displays permeable BRB, the retina becomes more permissive to gene delivery mediated by adeno-associated viral vectors (AAV). However, despite BRB permeability AAV particles injected intraocularly stay confined to the ocular compartment in this model. Our results indicat...

Materials

Name	Company	Catalog Number	Comments
C57BL6J mice strain	JANVIER LABS		mice
Ketamine 500	Virbac France		anesthetic
Xylazine Rompun 2%	Bayer Healthcare		anesthetic
Neosynephrine 5% Faure	Europhta		dilatant
Mydriaticum 0.5%	Thea		dilatant
Sterdex	Novartis		anti-inflammatory
Cryomatrix embedding resin	Thermo Scientific	6769006
Superfrost Plus Adhesion Slides	Thermo Scientific	10143352	slides
anti-laminin	Sigma	L9393	antibody
anti-rhodopsin clone 4D2	Millipore	MABN15	antibody
anti-glutamine synthetase clone GS-6	Millipore	MAB302	antibody
Anti-Glial Fibrillary Acidic Protein	Dako	334	antibody
PNA Lectin	Invitrogen	L32459	probe
Alexa fluor conjugated secondary antibodies	Invitrogen		antibody
Fluorsave reagent	Calbiochem	345789	mounting medium
QIAmp DNA Micro Kit	QIAGEN	56304
GoTaq DNA polymerase	Promega	M3001
Evans Blue dye	Sigma	E2129	dye
5 µm filter	Millipore
Sodium citrate	Sigma	S1804
Citric acid	Sigma	C1909-2.5KG
Formamide spectrophotometric	Sigma	295876-2L
Fluorescein	Sigma	F2456	dye
Micron III	Phoenix Research Labs		Microscopy system based on 3-CCD color camera, frame grabber, and off-the-shelf software enables researchers to image mouse retinas.
Insulin Syringes	Terumo	SS30M3109
Syringe 10 µl Hamilton	Dutscher	74487	Seringue 1701
Needle RN G33, 25 mm, PST 2	Fisher Scientific	11530332	Intravitreal Injection
UltraMicroPump UMP3	World Precision Instruments	UMP3	Versatile injector uses microsyringes to deliver picoliter volumes
UltraMicroPump (UMP3) (one) with SYS-Micro4 Controller	UMP3-1	Digital controller
Binocular magnifier SZ76	ADVILAB	ADV-76B2	Zoom 0.66 x 5 x LEDs with stand epi and dia / Retinas dissection
Spring scissors straight - 8.5 cm	Bionic France S.a.r.l	15003-08	Retinas dissection
curved Vanna scissor	15004-08
Pince Dumont 5	11254-20
Veriti 96-Well Thermal Cycler	Life technologies	4375786	Thermocycler
Ultrasonic cleaner	Laboratory Supplies	G1125P1T
Nanosep 30k omega tubes	VWR
Speedvac	Fisher Scientific	SC 110 A
Spectrofluorometer	TECAN	infinite M1000